Selective Roles of SGLT2 Inhibitors and GLP-1 Analogues to Reduce Cardiovascular Risk
[Speaker] In Chang Hwang/Seoul National Univ.,Korea
Efficacy and Mechanism of Action of SGLT2 Inhibitors in Heart Failure
[Speaker] Motoaki Sano/Keio Univ.,Japan
Novel Duo for Cardiometabolic Syndrome: SGLT2 Inhibitors and GLP-1
[Speaker] Jun Sung Moon/Youngnam Univ.,Korea
Natriuretic Effect of SGLT2 and Its Mechanisms in Patients with HF and T2DM
[Speaker] Kaoru Dohi/Mie Univ.,Japan
Discussion